V024-3473 Screening compound: 2-methylpropyl 4-{4-[(benzylcarbamoyl)amino]phenyl}-1-ethyl-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate

V024-3473 Screening compound: 2-methylpropyl 4-{4-[(benzylcarbamoyl)amino]phenyl}-1-ethyl-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate
V024-3473 Screening compound: 2-methylpropyl 4-{4-[(benzylcarbamoyl)amino]phenyl}-1-ethyl-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-3473
2-methylpropyl 4-{4-[(benzylcarbamoyl)amino]phenyl}-1-ethyl-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-3473

Molecular Formula

C26H32N4O3S (C26 H32 N4 O3 S)

Compound Name

2-methylpropyl 4-{4-[(benzylcarbamoyl)amino]phenyl}-1-ethyl-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate

IUPAC name

2-methylpropyl 4-{4-[(benzylcarbamoyl)amino]phenyl}-1-ethyl-6-methyl-2-sulfanylidene-1234-tetrahydropyrimidine-5-carboxylate

SMILES

CCN(C(C)=C(C(c(cc1)ccc1NC(NCc1ccccc1)=O)N1)C(OCC(C)C)=O)C1=S

InChI

InChI=1S/C26H32N4O3S/c1-5-30-18(4)22(24(31)33-16-17(2)3)23(29-26(30)34)20-11-13-21(14-12-20)28-25(32)27-15-19-9-7-6-8-10-19/h6-14,17,23H,5,15-16H2,1-4H3,(H,29,34)(H2,27,28,32)/t23-/m1/s1

InChI Key

JPKMANOAODSFDV-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD19726543

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.63

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.438

Distribution Coefficient, logD

4.438

Water Solubility, LogSw

-4.23

Polar Surface Area

69.226

Acid Dissociation Constant (pKa)

12.04

Base Dissociation Constant (pKb)

0.45

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

34.60

V024-3473 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with V024-3473 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-3473?
Check Price and Availability of V024-3473, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-3473 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-3473
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-3473
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-3473 available by request